Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SEIZSAFE

Financiado

Cerrado

Patient self adaptive system for detection recording and alert to caregivers of...

Patient self adaptive system for detection recording and alert to caregivers of night time seizures linked to private cloud platform for patient tracking and big data exploitation. Approximately 50 million people worldwide have epilepsy, an illness characterized by recurrent seizures. The estimated proportion of the general population with active epilepsy is between 4 and 10 per 1000 people. Globally, an est... ver más

28/02/2019

ENCORE LAB

856K€

Presupuesto del proyecto: 856K€

Líder del proyecto

ENCORE LAB La fabricación de sistemas e instrumentos de búsqueda, detección, navegación, orientación, aeronáuticos y náuticos; reguladores y controles...

TRL 4-5 | 130K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-02-28

SMEInst-06-2016-2017: Accelerating market introduction of...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ENCORE LAB

599.46K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NIGHTWATCH NightWatch Clinically proven detection and alert system fo... 71K€ Cerrado

ESPS Epileptic Seizure Prediction System ESPS Predicting and... 71K€ Cerrado

EPILEPSIAE Evolving Platform for Improving Living Expectation of Patien... 4M€ Cerrado

SERAS_v4.0 Seizure Risk Asessment for Epilepsy 3M€ Cerrado

EPINOSTICS Artificial Intelligence powered epilepsy diagnostics 3M€ Cerrado

NIGHTINGALE Connecting Patients and Carers using wearable sensor technol... 5M€ Cerrado

Duración del proyecto: 33 meses Fecha Inicio: 2016-05-04
Fecha Fin: 2019-02-28

Líder del proyecto

ENCORE LAB La fabricación de sistemas e instrumentos de búsqueda, detección, navegación, orientación, aeronáuticos y náuticos; reguladores y controles...

TRL 4-5 | 130K€

Presupuesto del proyecto 856K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Approximately 50 million people worldwide have epilepsy, an illness characterized by recurrent seizures. The estimated proportion of the general population with active epilepsy is between 4 and 10 per 1000 people. Globally, an estimated 2.4 million people are diagnosed with epilepsy each year. When patients suffer generalized convulsions there is a risk for them of being injured or having a cardiac arrest. Caregivers (usually patients’ relatives) reduce this risk by being alert and applying techniques such as holding the patients, putting them in a certain stance or providing them with the prescribed drugs. The problem worsens when seizures occur at night-time. Caregivers usually sleep in the same bedroom as patients and cannot rest due to the constant concern, leading to inconveniences such as loss of privacy, bad resting and higher risk for patients. This project aims to improve the lives of people affected by epilepsy, both patients and caregivers, providing them with an effective and unobtrusive device to monitor patients and alert caregivers during night-time seizures. This project consists on a patient-self-daptive system to detect, video-record and alert caregivers of night-time seizures, linked to a private cloud platform for medical tracking of patients and big data exploitation. The main innovative characteristics of SEIZSAFE are: • Patient-self-adaptive and self-learning algorithm for seizure detection • Camera and cloud platform for doctors • Reduced-cost technology • Medical validation The present project aims to expand SEIZSAFE in the European market. Considering a global market size of 1.2M epilepsy patients suffering night-time seizures, ENCORE foresees the uptake of 6.5% of the market in 5 years, which means 80,000 users by the end of 2022.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores